Phio Pharmaceuticals Corp. (NASDAQ:PHIO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Deming Other companies: Better for You Wellness Inc. (Director · Since at least Sep 30, 2021); Sorrento Therapeutics, Inc. (Director · Jul 11, 2016 – Sep 15, 2017 · Past); Albany Molecular Research Inc (Director · Jun 15, 2016 – Aug 31, 2017 · Past) | Director · Since at least Feb 19, 2025 |
| Keith L Brownlie Other companies: Celldex Therapeutics, Inc. (Director · Since at least Jun 15, 2017); Cancer Genetics Inc (Director · Jul 24, 2013 – May 22, 2014 · Past); Soligenix, Inc. (Director · Jun 21, 2012 – Sep 27, 2018 · Past) | Director · Mar 1, 2013 – Feb 13, 2019 · Past |
| Curtis Lockshin Other companies: Xenetic Biosciences, Inc. (Chief Sciencific Officer · Dec 4, 2019 – Dec 11, 2023 · Past) | Director · Since at least Mar 1, 2021 |
| Geert Cauwenbergh | Director · Mar 1, 2013 – Feb 17, 2023 · Past |
| Greg Young | VP Corporate Services · Since at least Oct 6, 2026 |
| H Paul Dorman | Director · Apr 18, 2013 – Feb 15, 2022 · Past |
| Jennifer Phillips | SVP of Regulatory & Corporate Affairs · Since at least Oct 19, 2026 |
| John M. Viglotti | SVP Corporate Services · Since at least Mar 10, 2026 |
| Jonathan E Freeman | Director · Since at least Sep 11, 2024 |
| Kimberly Man | Vice President of Program Development and Strategic Planning · Since at least Feb 23, 2026 |
| Lisa Carson | Chief Financial Officer · Since at least Feb 19, 2026 |
| Pamela Pavco | Chief Development Officer · Dec 16, 2016 – Feb 1, 2017 · Past |
| Patricia A Bradford | Director · Since at least Sep 11, 2025 |
| Robert Bitterman | President & Chief Executive Officer · Since at least Sep 29, 2026 |
| Robert L Ferrara | Director · Since at least May 20, 2025 |
| R. Todd Plott | Director · Since at least Jul 21, 2026 |